1. Home
  2. AMPH vs CDLR Comparison

AMPH vs CDLR Comparison

Compare AMPH & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CDLR
  • Stock Information
  • Founded
  • AMPH 1996
  • CDLR 2008
  • Country
  • AMPH United States
  • CDLR Denmark
  • Employees
  • AMPH N/A
  • CDLR N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CDLR
  • Sector
  • AMPH Health Care
  • CDLR
  • Exchange
  • AMPH Nasdaq
  • CDLR Nasdaq
  • Market Cap
  • AMPH 1.7B
  • CDLR 2.0B
  • IPO Year
  • AMPH 2014
  • CDLR N/A
  • Fundamental
  • Price
  • AMPH $36.41
  • CDLR $20.32
  • Analyst Decision
  • AMPH Buy
  • CDLR Strong Buy
  • Analyst Count
  • AMPH 4
  • CDLR 1
  • Target Price
  • AMPH $60.33
  • CDLR $37.00
  • AVG Volume (30 Days)
  • AMPH 672.6K
  • CDLR 25.8K
  • Earning Date
  • AMPH 02-26-2025
  • CDLR 11-26-2024
  • Dividend Yield
  • AMPH N/A
  • CDLR N/A
  • EPS Growth
  • AMPH 17.38
  • CDLR N/A
  • EPS
  • AMPH 3.01
  • CDLR 0.03
  • Revenue
  • AMPH $723,549,000.00
  • CDLR $201,002,677.00
  • Revenue This Year
  • AMPH $16.76
  • CDLR $130.71
  • Revenue Next Year
  • AMPH $8.00
  • CDLR $105.88
  • P/E Ratio
  • AMPH $12.09
  • CDLR $175.82
  • Revenue Growth
  • AMPH 20.33
  • CDLR 46.66
  • 52 Week Low
  • AMPH $34.60
  • CDLR $16.29
  • 52 Week High
  • AMPH $56.45
  • CDLR $28.75
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.93
  • CDLR 31.38
  • Support Level
  • AMPH $34.60
  • CDLR $20.10
  • Resistance Level
  • AMPH $36.66
  • CDLR $20.56
  • Average True Range (ATR)
  • AMPH 1.41
  • CDLR 0.36
  • MACD
  • AMPH 0.29
  • CDLR -0.08
  • Stochastic Oscillator
  • AMPH 43.54
  • CDLR 11.04

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning, and provides marine and engineering operations to the wind industry with a focus on safety and the environment. The company operates four offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Share on Social Networks: